[ET Net News Agency, 31 March 2020] Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
(02196) said its profit attributable to owners of the parent was RMB3.32 billion for the
year ended 31 December 2019, a year-on-year increase of 22.66%. The earnings per share
were RMB1.3. A final dividend of RMB0.39 will be distributed.
The revenue was RMB28.39 billion, a year-on-year increase of 14.87%. (RC)